Current Oncology Reports

The “new” era of oral antineoplastic drug therapy: Revisiting “old” concerns

Maurie Markman

Web alert

Minimal residual disease quantification in adult acute lymphoblastic leukemia

Heather Landau, Mark A. Weiss

Novel approaches in allogeneic stem cell transplantation

Esperanza B. Papadopoulos, Ann A. Jakubowski

Hairy cell leukemia

Claire Dearden, Monica Else

Philadelphia chromosome-positive acute lymphoblastic leukemia: Impact of imatinib treatment on remission induction and allogeneic stem cell transplantation

Tibor Kovacsovics, Richard T. Maziarz

Comparison of ABVD chemotherapy and a regimen including radiotherapy in patients with limited-stage Non-Hodgkin’s lymphoma

Carol S. Portlock

FDG-PET after two cycles of chemotherapy predicts treatment failure and Progression-free survival in Hodgkin’s lymphoma

Carol S. Portlock

Clinical and molecular prognostic factors in follicular lymphoma

Andrew J. Davies

Investigational strategies in autologous stem cell transplantation for follicular lymphoma

Oliver Weigert, Martin Dreyling, Michael Unterhalt, Wolfgang Hiddemann, Christian Buske

Mycosis fungoides and sezary syndrome: An update

Ellen J. Kim, Julie Lin, Jacqueline M. Junkins- Hopkins, Carmela C. Vittorio, Alain H. Rook

Non-Hodgkin’s lymphoma in children and adolescents

Neerav N. Shukla, Tanya M. Trippett

Sun exposure and mortality from melanoma

Kim Margolin

Distinct sets of genetic alterations in melanoma

Kim Margolin

Therapeutic targets in melanoma: MAPKinase pathway

Frank G. Haluska, Nageatte Ibrahim